Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:49 PM
Ignite Modification Date:
2025-12-24 @ 7:49 PM
NCT ID:
NCT02275403
Eligibility Criteria:
Inclusion Criteria:
* Patients with breast cancer, multiple myeloma, gastrointestinal cancer or gynaecological cancer who are receiving or who have received neurotoxic chemotherapy treatment for their condition
* The capacity to understand the patient information sheet and the ability to give written informed consent
* Willingness and ability to comply with scheduled visits and study procedures, including the self-report QoL questionnaires and patient diaries
* Age ≥ 18 years; no upper age limit
* CIPN of ≥ Grade II (CTCAE v4.03)
* Platelet count of ≥ 30 x 10\*9/L
* Neutrophil count of ≥ 0.5 x 10\*9/L
* MYMOP2 score of their most troubling CIPN symptom ≥ 3
Exclusion Criteria:
* Patients who have previously received acupuncture for neuropathy
* Patients who have received acupuncture for any indication, other than neuropathy, within the previous 6 months
* Women who are pregnant or breast feeding
* Co-morbidity with a bleeding disorder
* Patients with an aversion to needles
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02275403
Study Brief:
Protocol Section:
NCT02275403